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Background: Host genetic factors are thought to modulated the severity of disease caused by infection with the
2009 H1N1 pandemic influenza virus (H1N1pdm09). The human CCR5 gene encodes a cytokine receptor important
for cell-mediated immune response against H1N1pdm09. A 32-bp polymorphic deletion in the coding sequence of
CCR5, the so-called CCR5Δ32 allele, segregates in populations of European ancestry with a frequency of 8-15%. A
high proportion of CCR5Δ32 heterozygotes was reported in a sample of white Canadian critically-ill H1N1pdm09
infected subjects, suggesting an association with disease severity.
Methods: We recruited 29 H1N1pdm09 infected subjects from Southern Europe (mostly Italians) with a wide
clinical spectrum of disease symptoms; the sample included 7 subjects who developed acute respiratory distress
syndrome requiring extracorporeal membrane oxygenation. The CCR5Δ32 variant was genotyped in all subjects.
Results: The CCR5Δ32 allele was found in one single subject, who developed a very mild form and was not
hospitalized.
Conclusions: The CCR5Δ32 allele was not found to be associated with the risk of H1N1pdm09 infection or with a
severe disease course.
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The swine-origin H1N1 influenza A virus that appeared
in Mexico in 2009 (H1N1pdm09) caused the first flu
pandemic of the 21st century. H1N1pdm09 infection
resulted in a substantial diseases burden with a minority
of infected subjects developing life-threatening respiratory
complications. Estimates of H1N1pdm09-associated mor-
tality are similar in magnitude to that of seasonal
influenza, but most deaths occurred in healthy people
younger than 65 years old [1,2]. Also, strong differences
in mortality were observed depending on ethnicity and
geographic location [1,2]. Whereas these trends are likely
to be partially explained by epidemiological aspects (e.g.
previous exposure to antigenically similar viruses), host
genetic and non-genetic factors were proposed to play a
role. In particular, non-genetic risk factors were shown to
include pregnancy, morbid obesity, cardiovascular disease,* Correspondence: manuela.sironi@bp.lnf.it
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unless otherwise stated.diabetes, and immunosuppression [2]. Nonetheless, a large
majority of severely affected subjects were healthy and did
not present any risk condition, suggesting that genetic
effects might modulate H1N1pdm09 disease course.
Indeed, studies based on historical registries indicated
that genetic factors affect the risk of death due to influenza
virus infection [3]. Likewise, the familial aggregation of
influenza A/H5N1 cases, the paucity of cases among highly
exposed groups, and the occurrence of related cases
separated in time and space led Horby and coworkers
to indicate that host genetic factors play an important
role in the susceptibility to this infection [4].
Clearly, the identification of host genetic factors that
modulate the susceptibility to and the severity of influenza
virus infection is of paramount importance to develop
preventive strategies and therapeutic interventions.
Recently, a case–control study of 91 Mexican patients
with confirmed severe pneumonia from H1N1pdm09
infection identified three independent association signals
[5]. Nevertheless, no subsequent analysis addressed thetd. This is an Open Access article distributed under the terms of the Creative
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yield false positives, as noted [6]. Several other reports
have explored the role of human genetic variants in
the modulation of H1N1pdm09 infection severity, but
only two variants have been analyzed in at least two
independent studies. The first one, a functional variant
in the IFITM3 gene (rs12252), was originally described
in a cohort of 53 influenza UK cases who developed
severe respiratory complications [7]. The association
was confirmed in a study of H1N1 cases in China, where
the frequency of the minor predisposing genotype is much
higher [8]. Nonetheless, the rarity of the risk genotype
(only 3 homozygotes drove the association in the UK
study) suggests that this variant makes a contribution to
H1N1 disease severity in Europe. The second candidate
variant is represented by a 32-bp polymophic deletion in
the CCR5 gene, the so-called CCR5Δ32 allele, which is
almost exclusive to individuals with European ancestry.
In a Canadian sample of 9 Caucasian patients with severe
H1N1pdm09 infection Keynan et al. [9] found a nearly
5-fold enrichment of CCR5Δ32 heterozygotes compared
to the expectation based on allele frequency in popula-
tions with European ancestry. This association found
support by the description of a fatal case of H1N1pdm09
infection: the young patient was homozygous for the
CCR5Δ32 allele, a status that occurs in a small minority of
subjects (0.02% to 2% depending on the population) [10].
Also, studies in a Ccr5−/− mice have indicated that, when
infected with influenza A virus, these animals display
accelerated macrophage accumulation in the lungs and
increased mortality compared to wild-type mice [11].
Herein we investigated whether the CCR5Δ32 associates
with disease severity in H1N1pdm09 infected southern
European patients.
Methods
Patients
We analyzed 29 subjects with laboratory confirmed H1N1
infection who were referred to the Infectious Disease Unit
of the San Gerardo Hospital, Monza, Italy, in winter
2009–2010. Most patients described herein were recruited
immediately after the H1N1 outbreak in a relatively short
time period. Peripheral blood samples were obtained
from H1N1pdm09 infected patients as part of their care
pathway. All patients signed an informed consent allowing
leftover blood samples to be used for research purposes.
The informed consent form was approved by the Internal
Review Board of the San Gerardo Hospital and explicitly
mentioned the use of leftover samples for genetic research.
Samples were stored and processed anonymously. The
authors have presently no access to identifying information
and cannot relate genetic data to individual subjects.
The study was conducted in accordance with the ethical
standards of the Helsinki Declaration. All subjects were ofEuropean ancestry (27 Italians and one Spanish) with
the exception of a Chinese patient (in the mild form
group). The clinical characteristics of these subjects are
summarized in Table 1.
Genotyping
For all subjects genomic DNA was obtained from periph-
eral blood mononuclear cells. The CCR5Δ32 variant was
genotyped by PCR amplification using a forward primer
(CCR5-D32-F: TTTACCAGATCTCAAAAAGAAG) and
a fluorescently labelled reverse primer (CCR5-D32-R:
GGAGAAGGACAATGTTGTAGG, FAM). PCR-amplified
fluorescently tagged samples were run on 3500xL Genetic
Analyzer (Life Technologies) using the GeneScanTM 600
LIZ® size standard (Life Technologies). The PCR amplicons
were separated by size electrophoresis and the dye labeled
products were identified by fluorescence detection. Gene-
Mapper® Software Version 4.0 was applied to size the alleles
(Figure 1).
Results
We recruited 29 subjects with laboratory confirmed H1N1
infection. Twenty-one of these patients were hospital-
ized; seven of them developed acute respiratory distress
syndrome (ARDS) and required extracorporeal membrane
oxygenation (ECMO). These subjects are referred to as
having a severe flu form (Table 1); two of them were
overweight, one was diabetic, and one suffered from
non-Hodgkin lymphoma. The patient suffering from
non-Hodgkin lymphoma was not undergoing any therapy
and was disease-free at the moment of hospitalization;
the diabetic patient had his disease controlled through
therapy. Seven other subjects developed pulmonary disease,
required oxygen therapy administration alone and the
disease course did not present life-threatening respiratory
symptoms (intermediate gravity, Table 1). The seven
remaining hospitalized patients only required oxygen
therapy administration and the disease course presented
no complications (mild form, Table 1). Finally, 8 additional
infected subjects were not hospitalized (very mild form).
All patients survived their illness. For all of them the poly-
morphic 32 bp deletion in the CCR5 gene was genotyped.
The reported frequency of the CCR5Δ32 allele in Italy
is 0.055 (0.098 in Spain) [12], resulting in an expected
frequency of heterozygotes around 10%. Among the
H1N1pdm09-infected subjects only one was found to
carry the CCR5Δ32 allele: the patient developed a very
mild form and was not hospitalized. Thus, the CCR5Δ32
allele was not found to be associated with the risk of
H1N1pdm09 infection or with a severer disease course.
Discussion
We evaluate the possible association between the CCR5Δ32
allele and severe H1N1pdm09 infection in patients form
Table 1 Clinical characteristics and CCR5Δ32 allelic status for the 29 H1N1pdm09 patients
Flu form Disease course Number of subjects Males/females Self-reported
ancestry (number)
Number of CCR5Δ32
heterozygotes
Severe ARSD requiring ECMO 7 6/1 Italian (6), Spanish (1) 0
Intermediate Pulmonary disease requiring oxygen therapy 7 3/4 Italian (7) 0
Mild No complications, only oxygen administration 7 3/4 Italian (6), Chinese (1) 0
Very mild No hospitalization, no complications 8 4/4 Italian (8) 1
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for cell-mediated immune response against H1N1pdm09
[13,14] and the CCR5Δ32 allele confers increased sus-
ceptibility to symptomatic infection with other viral species
such as West Nile virus (WNV) [15]. In this latter case,
though, the association model is recessive - i.e. only
homozygotes are at higher risk of developing a severe
disease following WNV infection [15]. The recessive
model is consistent with the loss-of-function effect of
the 32-bp deletion in CCR5 and may apply to other
phenotype associations, as it also describes a strong [16]
but not complete [17] resistance to HIV-1 infection. The
previously reported association between the CCR5Δ32
and severe H1N1pdm09 infection implied a non-recessive
model, as a large excess of heterozygotes was described
among critically ill patients [9]. Data herein do notFigure 1 GeneScan analysis of a subject heterozygous for the CCR5Δ32
by capillary electrophoresis with a size standard (red peaks).confirm this finding and suggest that CCR5Δ32 does
not play a major role in modulating H1N1pdm09 infection
severity. It should be noted, however, that both Keynan’s [9]
and this study suffer from the limitation of the small sample
size and are underpowered to detect a recessive effect of
CCR5Δ32 on H1N1 disease course. Also, the CCR5Δ32
allele tends to vary in frequency with a latitudinal cline
[12], suggesting that population stratification might also
affect the association results for this variant. Likewise, the
rs12252 polymorphism in IFITM3 previously associated
with H1N1pdm09 disease severity shows strong frequency
variation depending on ancestry. Its frequency is very low
in Europe (but much higher in Asia) and a recent analysis
of 34 severe H1N1pdm09 patients from the UK detected
no association (whereas an effect of the rare homozygous
genotype was detected for mild influenza) [18].allele. Fluorescence-labelled PCR products (blue peaks) were separated
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Overall, results from these previous analyses together
with those reported herein indicate that larger sample
sizes will be required to perform robust association studies
for H1N1pdm09 disease severity. Thus, provided that host
genetics play a role in the susceptibility to this condition,
most of its determinants in European ancestry subjects
remain to be identified.
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